Mutations (loss of function) and other alterations of the ERBB4/HER4 receptor (also known as ALS19) have been linked to several neurological and psychiatric disorders, including ALS and schizophrenia (Table 1) [1, 4, 8–20, 37, 38]. This evidence concerns the gene ERBB4 and amyotrophic lateral sclerosis.